Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Lazard Capital Conference
Human Genome Sciences, Inc. logo. (PRNewsFoto/HUMAN GENOME SCIENCES, INC.)
ROCKVILLE, MD UNITED STATES
ROCKVILLE, Md., Nov. 17 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the Lazard Capital Markets 5th Annual Healthcare Conference will be webcast and may be accessed at www.hgsi.com.
A member of Human Genome Sciences' senior management team will present a corporate overview on Wednesday, November 19, 2008 at 11:00 AM Eastern Time.
Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.
HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at www.hgsi.com.
